Systemic therapy of aggressive fibromatosis in children and adolescents: Report of the Cooperative Weichteilsarkom Studiengruppe (CWS)
Pediatric Blood & Cancer Jan 10, 2018
Sparber-Sauer M, et al. - An exploration was carried out of the use of systemic therapy (ST) in pediatric patients with aggressive fibromatosis (AF). The conclusion drawn was that ST was possibly appropriate if a primary complete resection was not feasible and at relapse/progression after resection.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries